Here are the three healthcare AI companies that have landed funding rounds of $100 million-plus through Sept. 9, per the news outlet:
1. Abridge: $150 million. The ambient clinical documentation company sealed the series B funding Feb. 23. The round was co-led by investment firms Lightspeed Venture Partners and Redpoint Ventures and included the Mass General Brigham Artificial Intelligence and Digital Innovation Fund, Kaiser Permanente Ventures and CVS Health Ventures.
2. AKASA: $120 million. The healthcare revenue cycle automation platform secured the funding June 18.
3. Zephyr AI: $111 million. The AI precision medicine startup landed the series A funding March 13 that included Eli Lilly & Co. Columbia, Md.-based MedStar Health has previously invested in the company.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
